Synarc

Synarc is the world's largest Central Radiology service dedicated exclusively to clinical trials. Synarc's in-house radiologists and scientists are leading authorities in the use of medical imaging and molecular markers in drug development, and have pioneered many methods currently used in clinical trials. With six offices around the world, Synarc currently manages over 150 clinical trials, involving more than 50,000 patients at 1,500 sites worldwide. Our services integrate all aspects of the design and execution of imaging and molecular markers in clinical trials across a spectrum of diseases in Oncology, Arthritis, Osteoporosis, Neurology, and Orthopaedics.

Synarc headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $364.8M in funding across 24 round(s). With a team of 5001-10000 employees, Synarc is actively contributing to advancements in Health Care. Their latest funding round, Series B - Synarc, raised $10.2M. Discover more about their projects, partnerships, and impact on our platform.